Throne Biotechnologies
New Jersey
About Throne Biotechnologies
Throne's Stem Cell Educator Therapy is to fundamentally "reset" the immune system with a single dialysis-like procedure employing CB-SC stem cells in order to cure the underlying causes of autoimmune illnesses, such as diabetes and alopecia.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 1 – 10
- Total funding: $150.0K
- Last round: Grant (Aug 2022)
- Website: thronebio.com
- Phone: [email protected]
Industries & Categories
Biotechnology, Clinical Trials, Diabetes, Hospital, Therapeutics
Social Profiles
Canonical: https://fsome.com/organization/throne-biotechnologies-28603 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.